Genetic Testing for Alzheimer's: Understanding Risk Genes vs. Deterministic Genes

If you are a family caregiver or an early-stage patient wondering whether to get genetic testing for Alzheimer's, you are not alone. Many people worry about their risk, especially when a parent or sibling has the disease. The good news is that most genetic testing looks at risk genes, not deterministic ones, meaning a positive result does not guarantee you will develop Alzheimer's. This article will help you understand the difference between the two types of genes, what the test results really mean, and how to make an informed decision that feels right for you and your family. There are concrete steps you can take to manage your health and reduce your risk, regardless of your genetic makeup.

Key points

• Deterministic genes (APP, PSEN1, PSEN2) are rare and virtually guarantee early-onset Alzheimer's; risk genes (APOE e4) increase your likelihood but do not guarantee the disease.
• Most people with a family history of Alzheimer's do not carry deterministic genes; APOE e4 is the most common risk gene, carried by about 25-30% of the population.
• Having one copy of APOE e4 raises your risk two to three times; having two copies raises it about 10 to 14 times, but many people with the gene never develop Alzheimer's.
• Genetic testing is a personal decision that should be made with a genetic counselor or doctor, not through a direct-to-consumer test without counseling.
• Regardless of your genetic results, you can lower your overall risk through lifestyle: regular exercise, a healthy diet, managing blood pressure and cholesterol, staying socially active, and keeping your mind engaged.
• If you are a caregiver, prioritize your own mental and physical health; caregiver stress is a significant risk factor for cognitive decline.

What Are Deterministic Genes?

Deterministic genes are rare genetic mutations that virtually guarantee a person will develop Alzheimer's disease if they inherit them. These genes are associated with early-onset Alzheimer's, which typically appears before age 65. The three known deterministic genes are the amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2). If you inherit one of these mutations from a parent, you have a very high likelihood of developing the disease, often at a younger age. However, these mutations are extremely uncommon, accounting for less than 1% of all Alzheimer's cases. Most people with a family history of Alzheimer's do not carry these genes.

What Are Risk Genes?

Risk genes, on the other hand, do not guarantee that you will develop Alzheimer's. They simply increase your likelihood of developing the disease compared to the general population. The most well-known risk gene is APOE e4. Everyone inherits one of three versions of the APOE gene from each parent: e2, e3, or e4. Having one copy of the e4 variant raises your risk of developing late-onset Alzheimer's (after age 65) by about two to three times. Having two copies (one from each parent) raises your risk by about 10 to 14 times. However, many people with one or even two copies of APOE e4 never develop Alzheimer's, and many people without the gene do develop the disease. This is because Alzheimer's is influenced by many factors, including age, lifestyle, and other health conditions.

Why the Difference Matters for Your Decision

Understanding the difference between deterministic and risk genes is crucial when deciding whether to get tested. A deterministic gene result is a near-certainty, but it is very rare. A risk gene result, like APOE e4, is much more common but does not provide a definitive answer. The test cannot tell you if or when you will get Alzheimer's. It only tells you that your risk is higher or lower than average. This uncertainty can be emotionally challenging. Some people find relief in knowing their risk so they can take proactive steps, while others experience increased anxiety without any clear benefit. The decision is deeply personal and should be made with the guidance of a healthcare provider, ideally a genetic counselor, who can explain the implications and help you weigh the pros and cons.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

Discuss with your clinician

Ask your doctor: 'Given my family history, should I consider genetic testing for deterministic genes (APP, PSEN1, PSEN2) or only for the APOE e4 risk gene?'

Ask your doctor: 'If I test positive for APOE e4, what specific lifestyle changes or medical screenings would you recommend to lower my risk?'

Ask your doctor: 'How might my genetic test results affect my eligibility for clinical trials or new Alzheimer's treatments?'

Ask your doctor: 'What are the potential side effects of Alzheimer's drugs like lecanemab if I have one or two copies of APOE e4?'

Ask your doctor: 'Can you refer me to a genetic counselor who specializes in Alzheimer's and dementia?'

Ask your doctor: 'How will my insurance cover genetic testing and counseling? Are there any out-of-pocket costs I should expect?'

Related guides

• Understanding Early-Onset Alzheimer's: A Family Guide to What's Happening and What to Do Next
• APOE genotype and Alzheimer's risk levels
• Using the GEMS State Tool for dementia assessment and support
• Lifestyle steps to protect brain health from dementia
• caregiver stress and the caregiver's own dementia risk
• Anti-Amyloid Drugs (Lecanemab & Donanemab): What They Do for Early Alzheimer's
• The Mediterranean and MIND Diets for Brain Health: A Practical Guide for Caregivers
• Finding Your People Online: A Guide for Spouse Caregivers of Alzheimer’s and PCA

Sources

• PubMed
• AAFP
• Alzheimer's Association
• Mayo Clinic
• All Home Care Matters
• Dementia Careblazers
• The Dementia Doctor
• Wisconsin Alzheimer's Disease Research Center